Centre for Global Infectious Disease Analysis, Imperial College London (GIDA) - COVID-19

Grant number: MC_PC_19012

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $660,260
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Prof. Neil Ferguson
  • Research Location

    United Kingdom
  • Lead Research Institution

    Imperial College London
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This award is being made in recognition that key Centre staff have been redeployed from their usual work, and Centre resources utilised, to contribute to the first phase of a rapid research response to the COVID-19 pandemic. The MRC Centre for Global Infectious Disease Analysis, is at the forefront of delivering timely analysis to inform policy responses to emerging infectious disease threats, and was rapidly awarded an additional £0.5m to support their real-time analysis and modelling of the SARS-CoV2 pandemic and the impact of COVID-19.

Publicationslinked via Europe PMC

Last Updated:2 hours ago

View all publications at Europe PMC

Design and Implementation of a National SARS-CoV-2 Monitoring Program in England: REACT-1 Study.

Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England.

The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021.

Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow Immunoassay.

COVID-19: On the Disparity in Outcomes Between Military and Civilian Populations.

Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US.

Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021.

Long term intrinsic cycling in human life course antibody responses to influenza A(H3N2): an observational and modeling study.

A COVID-19 model for local authorities of the United Kingdom.